Martin Stammer - Stereotaxis Insider

Stereotaxis Inc -- USA Stock  

USD 0.74  0.031  4.37%

CFO and Principal Accounting Officer

Mr. Martin C. Stammer is Chief Financial Officer of Stereotaxis, Inc., since February 2013. He previously served as Vice President, Controller since August 2012 and as Corporationrationrate Controller from July 2011 to August 2012. He joined the Company as Senior Manager, Financial Reporting in October 2009. Prior to joining the Company, from 2003 to 2009, Mr. Stammer was employed in various roles and capacities at Deloitte Touche LLP, including most recently as Audit Manager
Age: 35  CFO Since 2014      
Stammer received his M.S. and B.S. in Accountancy from the University of Illinois and is a Certified Public Accountant.

Martin Stammer Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (23.39) % which means that it has lost $23.39 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (52.1) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 6 records

CFO Since

David GillEndoChoice Holdings Inc
Zvi BenDavidDarioHealth Corp
Simon MAEndoChoice Holdings Inc
Scott UllemEdwards Lifesciences Corporatio
James HennenVascular Solutions Inc
Jeffry KeyesDigirad Corporation

Entity Summary

Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Stereotaxis operates under Medical Appliances Equipment classification in USA and traded on OTC Market exchange.Stereotaxis Inc (STXS) is traded on OTC Market in USA. It is located in MISSOURI, U.S.A and employs 120 people. Stereotaxis is listed under Medical Equipment category by Fama And French industry classification.

Did you try this?

Run Equity Forecasting Now

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
Hide  View All  NextLaunch Equity Forecasting
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Stereotaxis Inc to your portfolio

Top Management

Stereotaxis Inc Leadership Team
Duane DeSisto, Director, MBA
Euan Thomson, Director
Eric Prystowsky, Director
Paul Brathwaite, President
Karen Duros, SVP
Frank Cheng, SVP, MBA
Susan Lanigan, President
David Giffin, VP, MBA
Arun Menawat, Director, MBA
Martin Stammer, CFO
Robert Messey, Director
Joseph Keegan, Director, Ph.D
Joseph Kiani, Director
William Mills, Chairman
Nathan Fischel, Director
David Benfer, Director, MBA
Fred Middleton, Director, MBA
David Fischel, Director, MBA

Stock Performance

Stereotaxis Performance Indicators